ZyVersa Therapeutics Inc (NASDAQ:ZVSA) has a beta value of 0.82 and has seen 1.07 million shares traded in the last trading session. The ZVSA stock price is -933.9% off its 52-week high price of $6.10 and 20.34% above the 52-week low of $0.47. If we look at the company’s 10-day average daily trading volume, we find that it stood at 21.69 million shares traded. The 3-month trading volume is 5.61 million shares.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) trade information

Over the past 30 days, the shares of ZyVersa Therapeutics Inc (NASDAQ:ZVSA) have changed -15.71%. Short interest in the company has seen 0.19 million shares shorted with days to cover at 0.2.

ZyVersa Therapeutics Inc (ZVSA) estimates and forecasts

The company’s shares have lost -51.93% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 58.00% over the past 5 years.

ZVSA Dividends

ZyVersa Therapeutics Inc is expected to release its next earnings report on 2024-Nov-14 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

ZyVersa Therapeutics Inc (NASDAQ:ZVSA)’s Major holders

Insiders own 0.13% of the company shares, while shares held by institutions stand at 7.28% with a share float percentage of 7.29%. Investors are also buoyed by the number of investors in a company, with ZyVersa Therapeutics Inc having a total of 8.0 institutions that hold shares in the company.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of May 31, 2025 , the former fund manager holds about 0.37% shares in the company for having 18.08 shares of worth $10667.0 while later fund manager owns 3.63 shares of worth $2139.0 as of May 31, 2025 , which makes it owner of about 0.07% of company’s outstanding stock.